IPI-493 is a bioactive compound. References: 4. Horton, William A.; Laederich, Melanie B. HSP90 inhibitors for the treatment for achondroplasia and other FGF receptor-mediated conditions. U.S. Pat. Appl. Publ. (2009), 62 pp. CODEN: USXXCO US 2009192133 A1 20090730 CAN 15212530 AN 2009:919310

纯度：≥98%

CAS：64202-81-9